Schedule 13D ownership disclosure
Ventyx Biosciences Inc
Common stock, par value $0.0001 per share · CUSIP: 92332V107
Event date: 2025-03-10
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- NSV Investments I, L.P.Reported CIK 0001889184
Shares: 3,143,114 · Class: 4.4%
- NSV Partners III, L.P.Reported CIK 0001309180
Shares: 4,524,720 · Class: 6.4%
- NSV Partners III GP, LLCReported CIK 0001889601
Shares: 4,524,720 · Class: 6.4%
- Somasundaram Subramaniam
Shares: 5,425,425 · Class: 7.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-25-001092
- Form type
- SCHEDULE 13D/A
- Filer
- NSV Investments I, L.P.
- CIK
- CIK 1889184
- Filed
- Mar 12, 2025
- Reporting period
- Mar 10, 2025
- Description
- Schedule 13D beneficial ownership